FDUS vs RARE · P/E 8.7, rev $126.4M vs rev $350.0M
Fidus Investment Corp (FDUS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Fidus Investment Corp (FDUS) is a asset management company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported FDUS revenue for 2025-12-31 was $126.4M. Net income was $82.4M. Revenue was up 2.6% from 2024-12-31 to 2025-12-31. FDUS currently screens at market cap $712.8M and trailing P/E 8.7.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
FDUS currently screens at market cap $712.8M and trailing P/E 8.7. RARE currently screens at market cap $2.79B.
Not investment advice. Open the FDUS and RARE stock pages for the full models.
Not investment advice.